Provider review
AM Rx review
Three numbers on one page, and not one of them is a plan price.
A membership sits alongside the medication charge, so the cash figure is part of a bill rather than the bill.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
AM Rx
$151/mo semaglutide cash, with a membership alongside it
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
There are three different numbers on this page and none of them is a plan price. The lowest is what somebody with the right insurance might pay as a copay for a branded product, which is an outcome of a plan nobody here can see rather than a rate this company sets. The highest is a branded list price used as an anchor, and it is not something this company charges anyone. The middle figure is the one closest to a real cash price for compounded semaglutide, and it sits inside a membership structure: the company's own material describes a membership, offers a combined doctor-and-medication plan as a distinct option, and lists among its own questions whether medication is billed separately under that plan. When a membership and a medication charge are both in play and the relationship between them is not resolved in public, the published figure is part of a bill rather than the bill, and quoting it as a price would understate what a reader actually pays. The insurance route is worth taking seriously on its own terms — prior authorizations are handled, government plans are addressed, and for a reader with coverage that path may beat every cash price. But it is a different product from the one this page is about, and it cannot be set against cash figures elsewhere. No dose appears behind any of the three numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You have insurance and want prior authorizations for a branded product handled for you
- You want one practice covering primary care and several other lines, not weight loss alone
- You are comfortable with a membership structure and want both molecules available under it
Look elsewhere if
- You are comparing cash prices. The advertised figure is part of a bill, not the whole of it
- You have no coverage. The lowest number shown depends entirely on a plan you may not have
- You want a figure tied to a milligram. None of the three carries a dose
What it actually costs
Price as published
The published figures are not the whole bill. Semaglutide is advertised "as low as $151/month" for a cash patient, beside branded products "as low as $25/month" with insurance — and the structure underneath is a membership, described on its own pages as the "AM Rx Membership" with a separate "Doctor + GLP-1" plan and a question in its own list asking whether medication is paid for separately · the $25 figure is an insurance copay outcome rather than a price this company sets · the same page anchors the cash figure against $1,349, a branded list price rather than anything it charges · no dose sits behind any figure · this storefront runs on a shared telehealth platform — its own homepage prints a promotional line naming a different brand's weight-loss program alongside its own, and the two carry the same address — which is context about the operator rather than a statement about the care, and separate brands are reviewed separately here · both compounded molecules are named, along with three-month supply options
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. Three figures appear and none is a plan price. The lowest is an insurance copay outcome for branded products rather than a rate this company sets; the highest is a branded list price used as an anchor; the middle one is a compounded cash figure sitting inside a membership structure whose own published questions ask whether medication is billed separately under it. A membership beside a medication charge means the advertised figure is part of a bill rather than the bill. No dose sits behind any of them and no low-dose product is offered. The insurance route, with prior authorizations handled, may genuinely beat every cash price for a covered reader — but it is a different product and cannot be compared against cash figures.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Both a cash route and an insurance route are offered, with prior authorizations handled.
- Both compounded molecules are named, with multi-month supply options described.
- The wider practice covers primary care and several other lines, not weight loss alone.
Pharmacy, labs and oversight
AM Rx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What AM Rx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
There are three different numbers on this page and none of them is a plan price. The lowest, twenty-five dollars, is what somebody with the right insurance might pay as a copay for a branded product, which is an outcome of a plan nobody here can see rather than a rate this company sets. The highest, thirteen hundred and forty-nine, is a branded list price used as an anchor and is not something AM Rx charges anyone. The middle figure, a hundred and fifty-one a month, is the one closest to a real cash price for compounded semaglutide, and it sits inside a membership structure: the company's own material describes a membership, offers a combined doctor-and-medication plan as a distinct option, and lists among its own questions whether medication is billed separately under that plan. When a membership and a medication charge are both in play and the relationship between them is not resolved in public, the published figure is part of a bill rather than the bill, and quoting it as a price would understate what a reader actually pays. The insurance route is worth taking seriously on its own terms — prior authorizations are handled, government plans are addressed, and for a reader with coverage that path may beat every cash price. But it is a different product from the one this page is about, and it cannot be compared against cash figures elsewhere. No dose appears behind any of the three numbers.
The honest cons
A membership sits alongside the medication charge, so the advertised figure is part of a bill.
- The lowest figure shown is an insurance copay outcome rather than a price the company sets.
- The cash figure is anchored against a branded list price this company does not charge.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
AM Rx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#235 of 373
Ordered with the companies that pay us first, and AM Rx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.